FAK and p53 protein interactions

Anti-Cancer Agents in Medicinal Chemistry

Volumn 11, Issue 7, 2011, Pages 617-619

  Golubovskaya, Vita M ^a,b   Cance, William G ^a,b  

^a ROSWELL PARK CANCER INSTITUTE   (United States)

^b UNIVERSITY AT BUFFALO   (United States)

Author keywords

Focal adhesion kinase; Metastasis; P53; Protein interaction; Tumor

Indexed keywords

FLUOROURACIL; FOCAL ADHESION KINASE; PROTEIN BAX; PROTEIN MDM2; PROTEIN P21; PROTEIN P53;

AMINO ACID SEQUENCE; ANGIOGENESIS; APOPTOSIS; CARCINOGENESIS; CELL ADHESION; CELL MOTILITY; CELL NUCLEUS; CELL PROLIFERATION; CELL SURVIVAL; CONFOCAL MICROSCOPY; CYTOPLASM; ENZYME ACTIVITY; ENZYME REPRESSION; HUMAN; IMMUNOPRECIPITATION; LYMPHANGIOGENESIS; METASTASIS; NONHUMAN; PROMOTER REGION; PROTEIN PROTEIN INTERACTION; REVIEW; TRANSCRIPTION INITIATION;

EID: 80051733727     PISSN: 18715206     EISSN: 18755992     Source Type: Journal    
DOI: 10.2174/187152011796817619     Document Type: Review

References (27)

1. Owens, L.V.; Xu, L.; Craven, R.J.; Dent, G.A.; Weiner, T.M.; Kornberg, L.; Liu, E.T.; Cance, W.G. Overexpression of the focal adhesion kinase (p125FAK) in invasive human tumors. Cancer Research, 1995, 55(13), 2752-2755.
2. Owens, L.V.; Xu, L.; Dent, G.A.; Yang, X.; Sturge, G.C.; Craven, R.J.; Cance, W.G. Focal adhesion kinase as a marker of invasive potential in differentiated human thyroid cancer. Ann. Surg. Oncol., 1996, 3(1), 100-105.
3. Cance, W.G.; Harris, J.E.; Iacocca, M.V.; Roche, E.; Yang, X.; Chang, J.; Simkins, S.; Xu, L. Immunohistochemical analyses of focal adhesion kinase expression in benign and malignant human breast and colon tissues: correlation with preinvasive and invasive phenotypes. Clin. Cancer Res., 2000, 6(6), 2417-2423.
4. Judson, P.L.; He, X.; Cance, W.G.; Van Le, L. Overexpression of focal adhesion kinase, a protein tyrosine kinase, in ovarian carcinoma. Cancer, 1999, 86(8), 1551-1556.
5. Lark, A.L.; Livasy, C.A.; Calvo, B.; Caskey, L.; Moore, D.T.; Yang, X.; Cance, W.G. Overexpression of focal adhesion kinase in primary colorectal carcinomas and colorectal liver metastases: immunohistochemistry and real-time PCR analyses. Clin. Cancer Res., 2003, 9(1), 215-222.
6. Lightfoot, H.M.,; Lark, A.; Livasy, C.A.; Moore, D.T.; Cowan, D.; Dressler, L.; Craven, R.J.; Cance, W.G. Upregulation of focal adhesion kinase (FAK) expression in ductal carcinoma in situ (DCIS) is an early event in breast tumorigenesis. Breast Cancer Res. Treat, 2004, 88(2), 109-116.
7. Kurenova, E.; Xu, L.-H.; Yang, X.; Baldwin, A.S., Jr.; Craven, R.J.; Hanks, S.K.; Liu, Z.-g.; Cance, W.G. Focal Adhesion Kinase Suppresses Apoptosis by Binding to the Death Domain of Receptor- Interacting Protein. Mol. Cell. Biol., 2004, 24(10), 4361-4371.
8. Golubovskaya, V.M.; Finch, R.; Cance, W.G. Direct interaction of the N-terminal domain of focal adhesion kinase with the Nterminal transactivation domain of p53 J. Biol. Chem., 2005, 280(26), 25008-25021.
9. Golubovskaya, V.M.; Cance, W.G. Focal adhesion kinase and p53 signaling in cancer cells. Int. Rev. Cytol., 2007, 263, 103-153.
10. Cance, W.G.; Golubovskaya, V.M. Focal Adhesion Kinase Versus p53: Apoptosis or Survival? Sci. Signal, 2008, 1(20), pe22.
11. Golubovskaya, V.; Kaur, A.; Cance, W. Cloning and characterization of the promoter region of human focal adhesion kinase gene: nuclear factor kappa B and p53 binding sites. Biochimica et Biophysica Acta (BBA) - Gene Struc. Exp., 2004, 1678(2-3), 111-125.
12. Golubovskaya, V.M.; Finch, R.; Kweh, F.; Massoll, N.A.; Campbell-Thompson, M.; Wallace, M.R.; Cance, W.G. P53 regulates FAK expression in human tumor cells. Mol. Carcinog., 2008, 47(5), 373-382.
13. Frame, M.C.; Patel, H.; Serrels, B.; Lietha, D.; Eck, M.J. The FERM domain: organizing the structure and function of FAK. Nat. Rev. Mol. Cell Biol., 11(11), 802-814.
14. Ilic, D.; Almeida, E.A.; Schlaepfer, D.D.; Dazin, P.; Aizawa, S.; Damsky, C.H. Extracellular matrix survival signals transduced by focal adhesion kinase suppress p53-mediated apoptosis. J. Cell Biol., 1998, 143(2), 547-560.
15. Lim, S.T.; Chen, X.L.; Lim, Y.; Hanson, D.A.; Vo, T.T.; Howerton, K.; Larocque, N.; Fisher, S.J.; Schlaepfer, D.D.; Ilic, D. Nuclear FAK promotes cell proliferation and survival through FERMenhanced p53 degradation. Mol. Cell, 2008, 29(1), 9-22.
16. Benoit, V.; de Moraes, E.; Dar, N.A.; Taranchon, E.; Bours, V.; Hautefeuille, A.; Taniere, P.; Chariot, A.; Scoazec, J.Y.; de Moura Gallo, C.V.; Merville, M.P.; Hainaut, P. Transcriptional activation of cyclooxygenase-2 by tumor suppressor p53 requires nuclear factor-kappaB. Oncogene, 2006, 25(42), 5708-5718.
17. Ko, B.S.; Chang, T.C.; Chen, C.H.; Liu, C.C.; Kuo, C.C.; Hsu, C.; Shen, Y.C.; Shen, T.L.; Golubovskaya, V.M.; Chang, C.C.; Shyue, S.K.; Liou, J.Y. Bortezomib suppresses focal adhesion kinase expression via interrupting nuclear factor-kappa B. Life Sci., 86(5-6), 199-206.
18. Wei, C.L.; Wu, Q.; Vega, V.B.; Chiu, K.P.; Ng, P.; Zhang, T.; Shahab, A.; Yong, H.C.; Fu, Y.; Weng, Z.; Liu, J.; Zhao, X.D.; Chew, J.L.; Lee, Y.L.; Kuznetsov, V.A.; Sung, W.K.; Miller, L.D.; Lim, B.; Liu, E.T.; Yu, Q.; Ng, H.H.; Ruan, Y. A global map of p53 transcription-factor binding sites in the human genome. Cell, 2006, 124(1), 207-219.
19. Golubovskaya, V.M.; Cance, W. Focal adhesion kinase and p53 signal transduction pathways in cancer. Front. Biosci., 2010, 15, 901-912.
20. Anaganti, S.; Fernandez-Cuesta, L.; Langerod, A.; Hainaut, P.; Olivier, M., P53-Dependent repression of focal adhesion kinase in response to estradiol in breast cancer cell-lines. Cancer Lett., 2010, 300(2), 215-224.
21. Mei, L., Xiong, W.C. FAK interaction with MBD2: A link from cell adhesion to nuclear chromatin remodeling. Cell Adh. Migr., 2010, 4(1), 77-80
22. Stewart, A.; Ham, C.; Zachary, I. The focal adhesion kinase aminoterminal domain localises to nuclei and intercellular junctions in HEK 293 and MDCK cells independently of tyrosine 397 and the carboxy-terminal domain. Biochem. Biophys. Res. Commun., 2002, 299(1), 62-73.
23. Beviglia, L.; Golubovskaya, V.; Xu, L.; Yang, X.; Craven, R.J.; Cance, W.G. Focal adhesion kinase N-terminus in breast carcinoma cells induces rounding, detachment and apoptosis. Biochem. J., 2003, 373(Pt 1), 201-210.
24. Jones, G.; Stewart, G. Nuclear import of N-terminal FAK by activation of the FcepsilonRI receptor in RBL-2H3 cells. Biochem. Biophys. Res. Commun., 2004, 314(1), 39-45.
25. Lobo, M.; Zachary, I. Nuclear localization and apoptotic regulation of an amino-terminal domain focal adhesion kinase fragment in endothelial cells. Biochem. Biophys. Res. Commun., 2000, 276(3), 1068-1074.
26. Chipuk, J.E.; Green, D.R. Cytoplasmic p53: Bax and Forward. Cell Cycle, 2004, 3(4), 429-431.
27. Golubovskaya, V.; Finch, R.; Zheng, M.; Kurenova, E.V.; Cance, W.G. The 7 amino-acid site in the proline-rich region of the Nterminal domain of p53 is involved in interaction with FAK and is critical for p53 functioning. Biochem. J., 2008 411(1), 151-160.